Market Update: February 6th
1. After experiencing significant declines over the past few sessions, particularly for the S&P 500 and Nasdaq due to a shift in tech stocks, there appears to be some upward momentum today. Nasdaq futures have risen, even after Amazon reported disappointing earnings last week, marking it as the worst week for both indexes since April 2025.
2. Bitcoin has shown signs of recovery this morning, bouncing back from an overnight scare where it nearly dipped below $60,000. The volatility in tech stocks and precious metals, especially silver, has triggered sell-offs and led to some forced liquidations in exchange-traded funds (ETFs). It’s worth noting Bitcoin reached a record high of over $126,000 last October.
3. There’s some debate about Amazon’s spending habits. Is the company overspending, or are they investing aggressively to lead the AI race? With their ownership of chips, they can offer cost-effective computing power. Their ambitious $200 billion capital spending plan for 2026, combined with a less-than-ideal profit prediction for this quarter, caused a significant drop in shares—down 8%. However, it’s important to highlight that their last quarter of 2025 saw strong growth in cloud services, which exceeded expectations.
4. Barclays has chosen to keep a buy rating on KKR, even though the private equity firm is heavily invested in enterprise software companies. This week, however, stocks in that sector have plummeted due to worries that AI could disrupt jobs. Salesforce, a key player in this space, did bounce back today, but overall, it’s still down about 10.5% for the week.
5. In a recent move, JPMorgan lowered its rating on Linde, the industrial gas giant, from buy to hold largely due to price pressures. With potential decreases in helium prices, there may be reason for caution. While Linde reported quarterly profits and sales, poor guidance has weighed on its stock this morning. That said, we believe this guidance could prove to be overly conservative.
6. The FDA announced last night that it would halt the release of Hims & Hers’ GLP-1 mimic drug, pointing out safety concerns. Following this, shares of Hims & Hers dropped nearly 9% after Novo Nordisk highlighted a counterfeit version of its weight-loss drug, Wegovy. Interestingly, Novo Nordisk’s shares, which had declined yesterday, jumped up by 7% today. Eli Lilly, a competitor, also saw a drop yesterday but managed to recover some of those losses this morning.
7. Stellantis experienced a staggering $26 billion restructuring charge, prompted by a business overhaul that included halting electric vehicle plans and reintroducing V8 engines for U.S. models. CEO Antonio Filosa stated that the company’s performance is on track. However, shares of Stellantis, which owns brands like Chrysler and Ram, fell by 24% this morning.
8. Goldman Sachs has upgraded Vistra, a power generation company, from buy to hold, attributing this to a recent drop in stock price and heightened expectations for an upgrade. The firm also mentioned that its recent agreement with Meta Platforms signifies its ability to secure sizable power purchase agreements. As a result, the stock price surged by more than 5%.
9. Wells Fargo has increased Bloom Energy’s price target from $95 to $130, crediting better-than-expected fourth-quarter earnings and a robust order backlog. This boost in outlook sent the stock soaring by over 13%. There’s definitely potential in this data center power play.
10. Piper Sandler has reduced Reddit’s price target from $290 to $205. The firm noted that, while the social media company reported another solid quarter and announced a $1 billion share buyback program, these results fell short of expectations. Oddly enough, the stock still climbed by 7% following the news.
